Browse online exclusive articles on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
It might stand to reason that as drivers get older and start to have various forms of visual dysfunction that it could affect their driving ability. It’s a common conversation among younger family members that their older family members have their vision screened for their safety on the road. A new study, however, suggests that vision screening might not have the impact that these well-meaning younger family members might think.
More than 2 years after being blinded in a “freak fireworks accident,” European football player Omar Elabdellaoui received a vision-restoring corneal transplant performed by Edward Holland, MD.
Research published in the British Journal of Ophthalmology suggests that grapes could be used as a training model. Zhang et al. compared the use of grapes, as a model for learning basic microsurgical skills, to the use of a virtual reality modulator.
Investigators from the John A. Moran Eye Center at the University of Utah, with collaboration from Scripps Research, have revived photoreceptor cells from organ donor eyes and restored communication between them. The research, according to a press release from the Moran Eye Center, “[stands] to transform brain and vision research.”
EyeWorld honors the lives of ophthalmologists who have died recently with recognition in this space.
“X-Rounds: Refractive Cataract Surgery to the Max” is a fast-paced session at the ASCRS Annual Meeting where members of the panel presented their answer to a question or thoughts on a topic in 2.5 minutes or less. The audience then voted for their favorite in each section.
Restasis (cyclosporine ophthalmic emulsion) was developed by Allergan and approved by the U.S. FDA in 2003. Now, after nearly 2 decades since its approval as a brand name drug indicated for symptoms of dry eye, a generic version of Restasis has been approved. It was a “long time coming,” according to Henry Perry, MD.
Attendees of the ASCRS Annual Meeting will have the opportunity to attend a new ASCRS Satellite CME Program, “Diversity, Equity and Inclusion: When Identifying the Problem Is Not Enough, Leadership Must Take Action,” on Monday from 8:00–9:30 a.m. Moderators Ann Caroline Fisher, MD, and Leon Herndon Jr., MD, spoke to EyeWorld about what to expect at the program that focuses on a social justice issue.
The ASCRS Film Festival is back after happening virtually the last 2 years due to the COVID-19 pandemic. Not only will the 2022 ASCRS Annual Meeting see the return of an in-person event, but it will also be a celebration of the 40th year of the festival. Shachar Tauber, MD, chairman of the event, talked about year’s Film Festival and his excitement about being involved.
Eric Donnenfeld, MD, EyeWorld chief medical editor, spoke to ASCRS Program Committee Chair Edward Holland, MD, about the 2022 ASCRS Annual Meeting in Washington, D.C.
